jim cramer now sees value in drug stock valeant after its ceo ‘delivered’
Published 6 years ago • 1.2K plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
7:52
pharma stocks are typically shunned by wall st. when people feel confident about economy: jim cramer
-
9:07
valeant pharmaceuticals ceo: challenging comeback | mad money | cnbc
-
1:17
jim cramer: drug stocks are underperforming ‘like nothing i’ve ever seen’
-
6:17
valeant pharmaceuticals ceo: new products, new name | mad money | cnbc
-
0:38
what jim cramer thinks about valeant pharmaceuticals shares
-
10:07
jim cramer reflects on big tech's bull run as nvidia notches a record close
-
4:14
lightning round: stay away from halliburton, says jim cramer
-
4:52
there's a ton of upside to nvidia's growth estimate next year, says melius’ ben reitzes
-
4:15
jim cramer on jazz pharmaceuticals buying gw pharma for $7.2 billion
-
7:55
jim cramer talks tesla's 'disappointing' robotaxi event
-
4:04
jim cramer takes a closer look at stocks that could be impacted by weight-loss drugs
-
6:30
jim cramer breaks down his new 'yev' stock criteria
-
3:45
are weight loss drugs to blame for a decline in gym sign-ups? jim cramer investigates
-
2:44
jim cramer: drug companies would be a good place to go if the market falls apart
-
4:42
valeant changes name to bausch health companies, ceo explains why
-
2:04
cramer’s stop trading: novartis
-
7:27
bausch health ceo on earnings and drug-industry regulation
-
9:05
jim cramer: these foreign drug stocks are worth betting on over domestics
-
8:42
astrazeneca ceo pascal soriot goes one-on-one with jim cramer
-
1:02
cramer’s mad dash: vertiv
-
3:00
cramer’s mad dash: bayer ag
-
9:22
jim cramer talks which stocks do well when the fed starts cutting rates